Testing a new PET scan for lung scarring
Part of Lungs & breathing clinical trials.
This trial is testing a new type of PET scan (FAPI PET) to help doctors see if lung scarring (fibrosis) is getting worse or getting better. It may help decide if a treatment change is needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with either fibrotic hypersensitivity pneumonitis or idiopathic pulmonary fibrosis.
- You are willing and able to have a PET/MRI scan.
- You are not pregnant.
- You do not need IV sedation for the scan (mild oral anxiety medicine is okay if you have a prescription and a driver).
- Your doctor is deciding whether to start, change, or add a new treatment for your lung disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging scan (called 18F-FAPI PET/CT) that may help detect scarring in the lungs, heart, or blood vessels. If you have a heart, lung, or blood vessel condition that could cause scarring, this scan might show damage earlier and help doctors plan better treatment.
This study uses a special PET scan (68Ga-1A12) to look for scarring (fibrosis) in your body. The scan may help doctors see where fibrosis is happening, which could guide your treatment.
This Phase 1 study tests a specialized imaging agent that can help show differences (heterogeneity) in lung scarring in idiopathic pulmonary fibrosis (IPF). It’s mainly about safety and whether the imaging works for people with certain genetic and lung-function features.
This early (Phase 1) study compares two types of PET-CT scans to see how well they detect and measure lung scarring (pulmonary fibrosis). It may help doctors choose the best scan test for diagnosis in the future.
This study tests a new type of PET/CT scan (FAPI-74) to see if it can detect areas of scarring (fibrosis) in the body. It may help doctors better understand and monitor conditions like certain cancers, infections after transplants, and heart inflammation.
This trial uses a special PET/MRI scan to look for early signs of lung scarring and inflammation using a “collagen-targeting” tracer. It may help doctors better identify early interstitial lung disease (IL D) and track it over time.
Hear when a new Fibrosis Lung trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.